MILD COGNITIVE IMPAIRMENT TREATMENT - AN OVERVIEW

If a screening test signifies a possible dilemma, you need to be entirely evaluated by a health practitioner to find out if there's a reversible trigger for your decline in cognition or to contemplate treatment choices if dementia is diagnosed.No new safety alerts were observed with continued lecanemab treatment. Soon after the very first 6 months,